Display search results for ** instead (39 products)
28 Sep 2018  |  North America
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
19 Sep 2018  |  North America
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
18 Sep 2018  |  North America
A Look at Growth Opportunities, Leading Vendors and Market Dynamics as Healthcare Braces for the Fourth Digital Wave
This report looks broadly at the role of reality technologies in healthcare, investigating the landscape for established and emerging products and vendors; top growth opportunities for major healthcare use cases; and the potential adoption trajectory and competitive dynamics impacting the market. Virtual reality refers to an interactive, immersive...
USD 1,125.00 save 25 %
04 Sep 2018  |  North America
Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities
The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally ...
USD 2,250.00 save 25 %
24 Aug 2018  |  North America
Optimizing Quality and Efficiency of Healthcare Delivery with AI
The study describes how AI technologies are paired with legacy healthcare IT systems to deal with the complexity & growth of medical data. Frost & Sullivan acknowledges that AI intuitively finds ways to convert these ever-expanding resources into actionable evidence for end users. In this study, Frost & Sullivan has forecast global revenue for prim...
13 Aug 2018  |  North America
Headways in Neuroimaging Continues to Play a Promising Care Pathway in Diagnosis and Treatment of Major Neurological Disorders
The scope of this research study covers the diagnostic applications of advanced imaging in neurological and neurodegenerative disorders. The geographical market covered is North America (US), Europe, and Asia-Pacific (APAC).--BEGIN PROMO--
This research service provides the following metrics:
01 Aug 2018  |  North America
Improved Workflow, Operational Efficiency, and Customer Journey Will be Available to All Stakeholders
Frost & Sullivan research found the visible market success of artificial intelligence (AI)-driven interactive virtual assistants (IVAs), such as Alexa from Amazon and the Google Assistant, has been matched by specialized IVA deployments in various vertical markets such as financial services, education, and retail. Healthcare has presented opportun...
USD 1,125.00 save 25 %
25 Jul 2018  |  North America
Evaluating Growth Patterns and Opportunities Across X-ray Mammography Sets
Over the last 20 years, hospitals and imaging centers in developed economies have adopted X-ray mammography equipment to screen and diagnose breast cancer. This has led to significant reduction in mortality and prompted emerging countries to invest in population-based, organized screening. Significant investments in mammography technology have pave...
10 Jul 2018  |  North America
Cybersecurity, Artificial Intelligence, Virtual Care, Digital Therapeutics, and the Movements of Major Tech Companies Continue to Advance the Market
At the beginning of this decade, Frost & Sullivan invented the definition of Digital Health to include convergent market segments, such as healthcare information technology (HCIT), remote patient monitoring (RPM), mobile health (mHealth), and telemedicine. Over the last five years, these segments have become increasingly sophisticated as new techno...
29 Jun 2018  |  North America
Using Cutting-edge Digital Technologies to Improve Patient Engagement and Adherence
Healthcare industry has undergone major transformation in the last decade with the incorporation of digital technologies. The changing technological as well as social trends, which focuses more on consumerism of healthcare which includes personalized interventions, making patients more accountable for their healthcare, disease awareness, is aimed t...